Detalhe da pesquisa
1.
A Highly Attenuated Panfilovirus VesiculoVax Vaccine Rapidly Protects Nonhuman Primates Against Marburg Virus and 3 Species of Ebola Virus.
J Infect Dis
; 228(Suppl 7): S660-S670, 2023 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37171813
2.
Single-dose attenuated Vesiculovax vaccines protect primates against Ebola Makona virus.
Nature
; 520(7549): 688-691, 2015 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-25853476
3.
Single-Dose Trivalent VesiculoVax Vaccine Protects Macaques from Lethal Ebolavirus and Marburgvirus Challenge.
J Virol
; 92(3)2018 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29142131
4.
Postexposure Efficacy of Recombinant Vesicular Stomatitis Virus Vectors Against High and Low Doses of Marburg Virus Variant Angola in Nonhuman Primates.
J Infect Dis
; 218(suppl_5): S582-S587, 2018 11 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-29939296
5.
Recombinant Isfahan Virus and Vesicular Stomatitis Virus Vaccine Vectors Provide Durable, Multivalent, Single-Dose Protection against Lethal Alphavirus Challenge.
J Virol
; 91(8)2017 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28148802
6.
Balance of cellular and humoral immunity determines the level of protection by HIV vaccines in rhesus macaque models of HIV infection.
Proc Natl Acad Sci U S A
; 112(9): E992-9, 2015 Mar 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-25681373
7.
Vaccination With a Highly Attenuated Recombinant Vesicular Stomatitis Virus Vector Protects Against Challenge With a Lethal Dose of Ebola Virus.
J Infect Dis
; 212 Suppl 2: S443-51, 2015 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26109675
8.
Neurovirulence and immunogenicity of attenuated recombinant vesicular stomatitis viruses in nonhuman primates.
J Virol
; 88(12): 6690-701, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24696472
9.
Astrophysics: Windy stars that go with a bang.
Nature
; 509(7501): 431-2, 2014 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-24848055
10.
Safety and comparative immunogenicity of an HIV-1 DNA vaccine in combination with plasmid interleukin 12 and impact of intramuscular electroporation for delivery.
J Infect Dis
; 208(5): 818-29, 2013 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23840043
11.
Cellular and humoral responses to an HIV DNA prime by electroporation boosted with recombinant vesicular stomatitis virus expressing HIV subtype C Env in a randomized controlled clinical trial.
Vaccine
; 41(16): 2696-2706, 2023 04 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36935288
12.
A highly attenuated Vesiculovax vaccine rapidly protects nonhuman primates against lethal Marburg virus challenge.
PLoS Negl Trop Dis
; 16(5): e0010433, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35622847
13.
A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for a soluble glycoprotein vaccine to prevent disease caused by Nipah or Hendra viruses.
Vaccine
; 39(38): 5436-5441, 2021 09 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34373117
14.
Protection against simian/human immunodeficiency virus (SHIV) 89.6P in macaques after coimmunization with SHIV antigen and IL-15 plasmid.
Proc Natl Acad Sci U S A
; 104(47): 18648-53, 2007 Nov 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-18000037
15.
Immune correlates of postexposure vaccine protection against Marburg virus.
Sci Rep
; 10(1): 3071, 2020 02 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-32080323
16.
Quadrivalent VesiculoVax vaccine protects nonhuman primates from viral-induced hemorrhagic fever and death.
J Clin Invest
; 130(1): 539-551, 2020 01 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31820871
17.
Safety and immunogenicity of a highly attenuated rVSVN4CT1-EBOVGP1 Ebola virus vaccine: a randomised, double-blind, placebo-controlled, phase 1 clinical trial.
Lancet Infect Dis
; 20(4): 455-466, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31952923
18.
Progress in the active immunotherapeutic approach to Alzheimer's disease: clinical investigations into AN1792-associated meningoencephalitis.
Neurodegener Dis
; 5(3-4): 194-6, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18322388
19.
Preclinical Development of Oncolytic Immunovirotherapy for Treatment of HPVPOS Cancers.
Mol Ther Oncolytics
; 10: 1-13, 2018 Sep 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-29998190
20.
Safety and tolerability of HIV-1 multiantigen pDNA vaccine given with IL-12 plasmid DNA via electroporation, boosted with a recombinant vesicular stomatitis virus HIV Gag vaccine in healthy volunteers in a randomized, controlled clinical trial.
PLoS One
; 13(9): e0202753, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30235286